Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 182, Issue 6, Pages 1791-1795Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/317614
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI-22774, AI-13342, AI-01341] Funding Source: Medline
Ask authors/readers for more resources
The echinocandin derivative caspofungin (MK-0991, L-743,872) inhibits 1,3-beta -D-glucan synthesis and is active against several medically important fungi but is relatively ineffective against Cryptococcus neoformans, To investigate the mechanism of C. neoformans resistance, the prevalence of 1,3- and 1,6-beta -D-glucan linkages was determined in cells grown with and without caspofungin, using affinity-purified antisera and gold particle immunoelectron microscopy. Cryptococcal strains ATCC 24067 (serotype D) and MY2061 (serotype A) were studied. Growth at 4 mug/mL of caspofungin reduced both glucan linkages in both strains, However, growth at 2 mug/mL resulted in reduced 1,6-beta -D-glucan linkage only for MY2061, Inhibition of 1,6-beta -D-glucan synthesis may be an additional mechanism of action for pneumocandins, The relatively low efficacy of caspofungin against C. neoformans may result from reduced activity against C. neoformans glucan synthase or from yet undiscovered mechanisms of action operative in other fungal pathogens but not in C. neoformans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available